Health Care Equipment & Services

Rule‑based insider sale by SOPHiA GENETICS’ chairman shows confidence, not panic, amid rising AI‑driven oncology demand and a 27% partner growth surge.

Inside BillionToOne’s mid‑July insider sales reveal disciplined portfolio moves, not a red flag – a steady divestiture that keeps investor confidence intact.

Insider sale by Walter Woltosz of Simulations Plus shares signals routine, rule‑based trading—evaluate its impact against the company’s growing health‑tech value‑based strategy.

Veeva’s insider buying signals strong confidence: President Eleni Nitsa’s July 1 trade shows long‑term commitment amid market volatility, backing the company’s growth in life‑science cloud tech.

Insightful Teladoc insider trading analysis: see how Bliss Kelly’s 10b5‑1 sale reflects portfolio balancing, not a bearish shift, and what it means for investors.

Alpha Tau Medical CFO buys 17,873 shares at $2.98, a discount to $13.19, signalling confidence in the company’s oncology device growth and potential upside.

Labcorp insider buying: Kyle Kathryn W’s RSU purchase signals confidence amid strong earnings, digital pathology growth, and a promising partnership with the Children’s Hospital of Philadelphia. Discover why this move matters for investors.

Inside Humana’s latest RSU purchases reveal board confidence and a bullish path driven by Medicare growth—why investors are watching the stock.

Discover how OMADA Health’s insiders use 10(b)(5) trading to signal confidence, boost valuation, and navigate a crowded virtual‑health market.

Agilon Health CFO’s July 1 sale of 2,311 shares at $111.74 shows routine liquidity, not a signal of change amid strategic growth and robust investor confidence.